Mycobacterium avium complex (MAC) is a group of bacteria related to tuberculosis that can cause severe lung infections and disseminated diseases, primarily affecting those with weakened immune systems.
Hyperbaric oxygen therapy may potentially enhance the efficacy of antimicrobial agents in treating Mycobacterium avium complex infections by increasing the oxygen concentration within affected tissues, thereby creating an unfavorable environment for bacterial growth.